CD8A and breast carcinoma: While there have been no reports concerning about immunogenic meaning of FCR in the metastatic lesion and primary tumours, several studies focusing on CD8+ TILs in the metastatic lesion and the corresponding primary tumour in breast cancer have been reported [32, 33].